TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Canopy Growth Corp. Is up 193% in 3 Months. Is More Coming?
Investing
The Latest Twist in Aurora Cannabis Inc.’s Pursuit of CanniMed Therapeutics Inc.
Investing
Canadian Regulators Are Sucking All the Fun Out of Legal Cannabis
Investing
Canopy Growth Corp.: Could a Hemp Strategy Support Exponential Growth?
Investing
Growth Investors: Should Canopy Growth Corp. Be a Top Pick Today?
Investing
3 Stocks That Will Soar With Legalization of Marijuana
Investing
Why Aphria Inc. Is My Least Favourite TSX-Traded Marijuana Stock
Investing
Why CanniMed Therapeutics Inc. Soared 17.18% on Thursday
Investing
Which Marijuana Stock Is the Better Buy: Aphria Inc. or Canopy Growth Corp.?
Investing
Canopy Growth Corp. Signs Up Another Province
Investing
Ranking Canada’s Top Marijuana Stocks for 2018